Connection

Beate Sander to Prognosis

This is a "connection" page, showing publications Beate Sander has written about Prognosis.
Connection Strength

0.009
  1. Nivolumab in the Treatment of Metastatic Renal Cell Carcinoma: A Cost-Utility Analysis. Am J Clin Oncol. 2018 12; 41(12):1235-1242.
    View in: PubMed
    Score: 0.009
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.